# Inhibrx Biosciences, Inc. (INBX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Inhibrx Biosciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/INBX/mda/fy2025/): filed 2026-03-19; accession 0002007919-26-000006 (https://www.sec.gov/Archives/edgar/data/2007919/000200791926000006/inbx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/INBX/mda/fy2024/): filed 2025-03-17; accession 0002007919-25-000019 (https://www.sec.gov/Archives/edgar/data/2007919/000200791925000019/inbx-20241231.htm)

Back to /company/INBX/